ClinicalTrials.gg
RecruitingNCT07627399BESTCAREICTUSUpdated Jun 4, 2026

Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)

An interventional study of BEST CARE ICTUS_HC BUNDLE in Stroke, Acute Stroke and Ischemic Stroke, sponsored by University of Malaga. Recruiting at 4 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by University of Malaga · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
700
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate whether a multicomponent nurse-led intervention (BEST CARE ICTUS_HC) can reduce stroke-related complications and improve recovery in adults (18 years and older) hospitalized with an acute ischemic or hemorrhagic stroke in hospitals without specialized Stroke Units. The main questions it aims to answer are:

  1. Does the implementation of the program increase the early and correct detection of swallowing difficulties (dysphagia) to prevent pneumonia?
  2. Does the program reduce the severity of attention problems (hemineglect) and improve the patients' quality of life up to 6 months after discharge?

Researchers will compare patients receiving the BEST CARE ICTUS_HC program to patients receiving usual hospital care to see if this new approach improves patient safety and long-term functional recovery.

Participants will:

  • Receive either the usual hospital care for stroke or the BEST CARE ICTUS_HC nursing program, depending on the study phase of the hospital.
  • Be screened for swallowing problems using a standardized test before receiving any food or drink.
  • Be cared for in an adapted environment (FLECHA Project) that uses visual signs and room organization to help with orientation and safety.
  • Have their temperature, blood sugar, and blood pressure monitored under a strict specialized protocol.
  • Be contacted by phone 30 days and 6 months after leaving the hospital to answer questions about their health and quality of life.
Read the detailed description

#Background and Context# Significant disparities exist in acute stroke outcomes depending on the type of hospital where a patient is admitted. In the Province of Malaga, peripheral hospitals lack specialized Stroke Units, meaning patients are managed in general internal medicine or standard hospitalization wards. Evidence suggests that nurse-led protocols (such as the FeSS protocols) can reduce mortality and complications like Stroke-Associated Pneumonia (SAP), yet these are rarely standardized in non-specialized settings.

The BEST CARE ICTUS_HC model aims to bridge this gap by implementing a structured bundle of care designed to minimize preventable complications and standardize nursing excellence in these peripheral centers.

The study follows the RE-AIM framework to assess reach, effectiveness, adoption, implementation, and maintenance. In accordance with the RE-AIM framework, the study will go beyond mere clinical efficacy to analyze how the intervention's integration into routine practice modifies professional behaviors and healthcare delivery processes.

#Description of the intervention#

The intervention employs a five-pillar strategy to enhance patient safety and clinical outcomes:

  1. Educational Outreach: Intensive training for nursing staff in peripheral wards on stroke pathophysiology and the "compensatory care" model.
  2. Dysphagia and Complication Prevention: Systematic use of the Modified Swallowing Assessment (MSA) to prevent aspiration and pneumonia, replacing informal clinical judgment.
  3. The "FLECHA" Project (Environmental Adaptation and Compensatory Care):

    • Visual Signaling System: Use of standardized, color-coded pictograms and directional arrows placed at the patient's bedside. This system provides an immediate visual cue to healthcare staff and family members regarding the stroke-affected side, ensuring all interactions account for the patient's specific deficits.
    • Therapeutic Spatial Reorganization: Strategic modification of the patient's immediate environment (arrangement of furniture, bedside tables, and personal items). This is designed to either encourage active visual scanning toward the neglected side (stimulation) or to safely compensate for the deficit, depending on the patient's clinical status and safety needs.
    • Digital Integration of Personalized Care: Implementation of bedside QR codes that provide instant access to evidence-based nursing protocols. These digital care plans are tailored to the specific type of stroke and its lateralization, offering precise guidance on therapeutic positioning, safe mobilization techniques, and the management of invasive devices (e.g., catheters or IV lines) to prevent secondary complications.
  4. Physiological Control Protocols: Algorithms for the strict monitoring of temperature, blood glucose, and blood pressure to prevent secondary brain injury.
  5. Invasive Device Stewardship: Protocols for the early removal of catheters to reduce hospital-acquired infections and promote early mobilization.

The comparator will be the usual care provided by each unit. During the control period, hospitals will provide standard care according to their existing institutional protocols.

#Data Collection and Analysis# Data will be collected at baseline (admission), during hospitalization (daily monitoring), at discharge, and via follow-up (phone) at 30 days and 6 months. An "Intention-to-Treat" analysis will be performed using Generalized Linear Mixed Models (GLMM) to account for the clustering effect of hospitals and the time effect inherent in the stepped-wedge design.

02

Conditions studied

  • Stroke
  • Acute Stroke
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Cerebrovascular Disorders
  • Deglutition Disorders
  • Perceptual Disorders
  • Unilateral Neglect
  • Pneumonia, Aspiration

Keywords

  • Acute Stroke
  • Nursing Care
  • Dysphagia Screening
  • Unilateral Neglect
  • Multicomponent Intervention
  • Care Bundle
  • Stepped-Wedge Design
  • Deglutition
  • Quality of life
  • Hyperglycemia
  • Fever
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 700 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Malaga is the lead sponsor of 121 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older.
  • Clinical diagnosis of acute ischemic or hemorrhagic stroke.
  • Admission to conventional hospitalization units (Internal Medicine) in regional hospitals without specialized Stroke Units.

Exclusion criteria

Exclusion Criteria:

  • Patients admitted for a cause other than stroke who develop a stroke during their hospital stay (in-hospital stroke).
  • Patients subjected to invasive neurological procedures.
  • Patients undergoing invasive procedures, such as thrombectomy, who require transfer to a referral hospital and remain there for more than 48 hours.
  • Patients with deterioration of the level of consciousness that prevents the performance of dysphagia testing.
  • Patients that have been taken care of by Nurses and Nursing Assistants with >4 weeks of work experience in Stroke Units in the last 12 months
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
700 participants (estimated)

Study arms

  • No intervention
    No Intervention: usual care (control phase)

    Patients receive standard clinical care according to the existing protocols of each Internal Medicine Unit before the hospital crosses over to the intervention phase. In this phase, dysphagia screening is not standardized and relies on routine clinical assessment and medical history records.

  • Experimental
    Experimental: BEST CARE ICTUS_HC (intervention phase)

    1\) 3-hour training for staff on stroke care, dysphagia, and the "FLECHA" project. 2) Mandatory use of Modified Swallowing Assessment (MSA). 3) Compensatory care strategies (pictograms, spatial reorganization for hemineglect). 4) QR code-guided specific care plans. During the implementation, in addition to the educational intervention for nurses, several complementary strategies will be employed: local leadership, analysis of barriers and facilitators, audit and feedback, provision of resources and materials, evaluation of intervention fidelity, and outreach facilitation.

    Other: BEST CARE ICTUS_HC BUNDLE

Interventions

  • OtherBEST CARE ICTUS_HC BUNDLE

    Multicomponent nursing intervention including: 1) Specialized staff training on acute stroke care. 2) Systematic dysphagia screening using the Modified Swallowing Assessment (MSA). 3) Implementation of the "FLECHA Project", a compensatory care model that harmonizes all care delivery based on stroke laterality aimed at developing early functional rehabilitation for unilateral neglect, hemiplegia, hemiparesis, and anosognosia (strategies include use of bedside pictograms, spatial reorganization, and QR-guided specific care plans). 4) Protocols for physiological stability monitoring and early device removal.

06

What researchers measure

Primary outcomes

  1. Proportion of participants with detected post-stroke dysphagia

    Identification of swallowing difficulties. Control Group: Dyspaghia detection based on usual care (standard clinical observation and records). Intervention Group: Dysphagia detection using the Modified Swallowing Assessment (MSA) tool.

    Time frame: Measured at hospital admission (baseline) and at hospital discharge (average of 9 days).

  2. Catherine Bergego Scale (CBS) score for Hemineglect

    The CBS is a functional assessment of unilateral neglect. It consists of 10 items related to daily living activities. Scores range from 0 to 30, where 0 indicates no neglect and 30 indicates severe neglect.

    Time frame: At hospital admission (baseline) and at hospital discharge (average of 9 days).

  3. Health-Related Quality of Life (HRQoL).

    Measured using the SF-36 Health Survey in both groups. The survey covers eight health domains, with scores ranging from 0 to 100 (higher scores indicate better health status).

    Time frame: At hospital discharge, 30 days post-discharge, and 6 months post-discharge.

Secondary outcomes

  1. Mortality

    Incidence of death from any cause in both groups.

    Time frame: At hospital discharge, 30 days post-discharge, and 6 months post-discharge.

  2. Mean Systolic Blood Pressure during hospitalization.

    Average of systolic blood pressure readings recorded to assess physiological stability. Unit of measurement: millimeters of mercury (mmHg).

    Time frame: From hospital admission (baseline) up to hospital discharge (average of 9 days).

  3. Mean Body Temperature during hospitalization.

    Average of body temperature readings measured daily. Unit of measurement: degrees Celsius (°C).

    Time frame: From hospital admission (baseline) up to hospital discharge (average of 9 days).

  4. Mean Capillary Glycemia during hospitalization.

    Average of blood glucose levels.

    Time frame: From hospital admission (baseline) up to hospital discharge (average of 9 days). Unit of measurement: milligrams per deciliter (mg/dL)

  5. Incidence of Stroke-Associated Pneumonia (SAP)

    Number of participants who develop pneumonia according to the PISCES criteria (Pneumonia in Stroke Consensus).

    Time frame: Through hospital discharge (average of 9 days)

  6. Environmental Adaptation Compliance (Intervention Group).

    Measured using an Intervention Checklist. It evaluates the daily implementation of: spatial reorganization, placement of visual cues (pictograms), and accessibility of QR-coded care plans.

    Time frame: Daily from hospital admission up to hospital discharge (average of 9 days).

  7. Duration of invasive device use

    Time in days from insertion until removal of invasive devices to evaluate the impact of early removal protocols. Specific measures include the duration of: venous access (peripheral catheters), nasogastric tubes, urinary catheters, and other catheterizations.

    Time frame: During hospitalization (from admission to discharge).

Other outcomes

  1. Sociodemographic Variables

    Registration of sex, age, educational level, main caregiver availability and main caregiver's sex.

    Time frame: At hospital admission.

  2. Clinical Characterization

    Assessment of comorbidities (Charlson Comorbidity Index), type of stroke (ischemic/hemorrhagic), affected side, and prescribed treatments.

    Time frame: At hospital admission.

  3. Length of Hospital Stay.

    Total number of days from hospital admission to discharge.

    Time frame: Through hospital discharge (average of 9 days).

  4. All-cause hospital readmission rate at 30 days.

    Proportion of participants readmitted to the hospital for any cause within 30 days after discharge.

    Time frame: 30 days after hospital discharge.

  5. Number of rehabilitation sessions received.

    Total count of rehabilitation sessions received by the participant.

    Time frame: Up to 6 months post-discharge.

  6. Functional Independence measured by the Barthel Index.

    Assessed using the Barthel Index (activities of daily living) and the Modified Rankin Scale (mRS) (global disability) in both groups.

    Time frame: At hospital admission (baseline) and at hospital discharge (average of 9 days)

  7. Global disability measured by the Modified Rankin Scale (mRS).

    The mRS is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke. Scores range from 0 (no symptoms) to 6 (death). Higher scores indicate greater disability.

    Time frame: At hospital admission (baseline) and at hospital discharge (average of 9 days).

07

Study locations

1 of 4 sites recruiting
08

References and documents

Publications

  • Eltringham SA, Kilner K, Gee M, Sage K, Bray BD, Pownall S, Smith CJ. Impact of Dysphagia Assessment and Management on Risk of Stroke-Associated Pneumonia: A Systematic Review. Cerebrovasc Dis. 2018;46(3-4):99-107. doi: 10.1159/000492730. Epub 2018 Sep 10. PubMed 30199856 ↗
  • Azouvi P, Bartolomeo P, Beis JM, Perennou D, Pradat-Diehl P, Rousseaux M. A battery of tests for the quantitative assessment of unilateral neglect. Restor Neurol Neurosci. 2006;24(4-6):273-85. PubMed 17119304 ↗
  • Perry L. Screening swallowing function of patients with acute stroke. Part two: Detailed evaluation of the tool used by nurses. J Clin Nurs. 2001 Jul;10(4):474-81. doi: 10.1046/j.1365-2702.2001.00502.x. PubMed 11822495 ↗
  • Wolfson M, Champion H, McCoy TP, Rhodes SD, Ip EH, Blocker JN, Martin BA, Wagoner KG, O'Brien MC, Sutfin EL, Mitra A, Durant RH. Impact of a randomized campus/community trial to prevent high-risk drinking among college students. Alcohol Clin Exp Res. 2012 Oct;36(10):1767-78. doi: 10.1111/j.1530-0277.2012.01786.x. Epub 2012 Jul 23. PubMed 22823091 ↗
  • Middleton S, Levi C, Ward J, Grimshaw J, Griffiths R, D'Este C, Dale S, Cheung NW, Quinn C, Evans M, Cadilhac D. Fever, hyperglycaemia and swallowing dysfunction management in acute stroke: a cluster randomised controlled trial of knowledge transfer. Implement Sci. 2009 Mar 16;4:16. doi: 10.1186/1748-5908-4-16. PubMed 19291323 ↗
  • Bravata DM, Daggett VS, Woodward-Hagg H, Damush T, Plue L, Russell S, Allen G, Williams LS, Harezlak J, Chumbler NR. Comparison of two approaches to screen for dysphagia among acute ischemic stroke patients: nursing admission screening tool versus National Institutes of Health stroke scale. J Rehabil Res Dev. 2009;46(9):1127-34. doi: 10.1682/jrrd.2008.12.0169. PubMed 20437319 ↗
  • Urimubenshi G, Langhorne P, Cadilhac DA, Kagwiza JN, Wu O. Association between patient outcomes and key performance indicators of stroke care quality: A systematic review and meta-analysis. Eur Stroke J. 2017 Dec;2(4):287-307. doi: 10.1177/2396987317735426. Epub 2017 Oct 5. PubMed 31008322 ↗
  • Paley L, Williamson E, Bray BD, Hoffman A, James MA, Rudd AG; SSNAP Collaboration. Associations Between 30-Day Mortality, Specialist Nursing, and Daily Physician Ward Rounds in a National Stroke Registry. Stroke. 2018 Sep;49(9):2155-2162. doi: 10.1161/STROKEAHA.118.021518. PubMed 30354982 ↗
  • Purvis T, Middleton S, Craig LE, Kilkenny MF, Dale S, Hill K, D'Este C, Cadilhac DA. Inclusion of a care bundle for fever, hyperglycaemia and swallow management in a National Audit for acute stroke: evidence of upscale and spread. Implement Sci. 2019 Sep 2;14(1):87. doi: 10.1186/s13012-019-0934-y. PubMed 31477125 ↗
  • Middleton S, Pfeilschifter W. International translation of Fever, Sugar, Swallow Protocols: The Quality in Acute Stroke Care Europe Project. Int J Stroke. 2020 Aug;15(6):591-594. doi: 10.1177/1747493020915130. Epub 2020 Apr 16. PubMed 32299312 ↗
  • Middleton S, Lydtin A, Comerford D, Cadilhac DA, McElduff P, Dale S, Hill K, Longworth M, Ward J, Cheung NW, D'Este C; QASCIP Working Group and Steering Committee. From QASC to QASCIP: successful Australian translational scale-up and spread of a proven intervention in acute stroke using a prospective pre-test/post-test study design. BMJ Open. 2016 May 6;6(5):e011568. doi: 10.1136/bmjopen-2016-011568. PubMed 27154485 ↗
  • Middleton S, Coughlan K, Mnatzaganian G, Low Choy N, Dale S, Jammali-Blasi A, Levi C, Grimshaw JM, Ward J, Cadilhac DA, McElduff P, Hiller JE, D'Este C. Mortality Reduction for Fever, Hyperglycemia, and Swallowing Nurse-Initiated Stroke Intervention: QASC Trial (Quality in Acute Stroke Care) Follow-Up. Stroke. 2017 May;48(5):1331-1336. doi: 10.1161/STROKEAHA.116.016038. Epub 2017 Apr 7. PubMed 28389609 ↗
  • Pinero Saez S, Sanz Aznarez AC, Ruiz Garcia MV, Gonzalez Garcia MJ, Mena Sucunza L, Corcoles Jimenez MP; en nombre del Grupo de Trabajo del Programa de implantacion de buenas practicas en centros comprometidos con la excelencia en cuidados(R). Implementation of the Best practice guideline: Stroke assessment across the continuum of care in hospitalised patients. Enferm Clin (Engl Ed). 2020 May-Jun;30(3):160-167. doi: 10.1016/j.enfcli.2019.10.026. Epub 2020 Apr 14. English, Spanish. PubMed 32303467 ↗
  • Hammond L, Conroy T, Murray J. Exploring oral care practices, barriers, and facilitators in an inpatient stroke unit: a thematic analysis. Disabil Rehabil. 2023 Mar;45(5):796-804. doi: 10.1080/09638288.2022.2040616. Epub 2022 Feb 21. PubMed 35188869 ↗
  • Baatiema L, Otim ME, Mnatzaganian G, de-Graft Aikins A, Coombes J, Somerset S. Health professionals' views on the barriers and enablers to evidence-based practice for acute stroke care: a systematic review. Implement Sci. 2017 Jun 5;12(1):74. doi: 10.1186/s13012-017-0599-3. PubMed 28583164 ↗
  • Clare CS. Role of the nurse in acute stroke care. Nurs Stand. 2020 Apr 1;35(4):75-82. doi: 10.7748/ns.2020.e11482. Epub 2020 Mar 30. PubMed 32227723 ↗
  • Green TL, McNair ND, Hinkle JL, Middleton S, Miller ET, Perrin S, Power M, Southerland AM, Summers DV; American Heart Association Stroke Nursing Committee of the Council on Cardiovascular and Stroke Nursing and the Stroke Council. Care of the Patient With Acute Ischemic Stroke (Posthyperacute and Prehospital Discharge): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association. Stroke. 2021 May;52(5):e179-e197. doi: 10.1161/STR.0000000000000357. Epub 2021 Mar 11. PubMed 33691469 ↗
  • Langhorne P, Ramachandra S; Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database Syst Rev. 2020 Apr 23;4(4):CD000197. doi: 10.1002/14651858.CD000197.pub4. PubMed 32324916 ↗
  • Pollock A, Hazelton C, Rowe FJ, Jonuscheit S, Kernohan A, Angilley J, Henderson CA, Langhorne P, Campbell P. Interventions for visual field defects in people with stroke. Cochrane Database Syst Rev. 2019 May 23;5(5):CD008388. doi: 10.1002/14651858.CD008388.pub3. PubMed 31120142 ↗
  • Gillen RW, Fusco-Gessick B, Harmon EY. How We Assess Spatial Neglect Matters: Prevalence of Spatial Neglect as Measured by the Catherine Bergego Scale and Impact on Rehabilitation Outcomes. Am J Phys Med Rehabil. 2021 May 1;100(5):443-449. doi: 10.1097/PHM.0000000000001710. PubMed 33538488 ↗
  • Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, Pobric G, Vail A, Bowen A. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD003586. doi: 10.1002/14651858.CD003586.pub4. PubMed 34196963 ↗
  • Tucker N, Stoffel JM, Hayes L, Jones GM. Blood Pressure Management Following Acute Ischemic Stroke: A Review of Primary Literature. Crit Care Nurs Q. 2020 Apr/Jun;43(2):109-121. doi: 10.1097/CNQ.0000000000000297. PubMed 32084057 ↗
  • Savopoulos C, Kaiafa G, Kanellos I, Fountouki A, Theofanidis D, Hatzitolios AI. Is management of hyperglycaemia in acute phase stroke still a dilemma? J Endocrinol Invest. 2017 May;40(5):457-462. doi: 10.1007/s40618-016-0584-8. Epub 2016 Nov 21. PubMed 27873213 ↗
  • Zapata-Arriaza E, Serrano-Gotarredona P, Navarro-Herrero S, Moniche F, Pardo-Galiana B, Pallisa E, Vega-Salvatierra A, Mancha F, Escudero-Martinez I, Bustamante A, Montaner J. Chest Computed Tomography Findings and Validation of Clinical Criteria of Stroke Associated Pneumonia. J Stroke. 2019 May;21(2):217-219. doi: 10.5853/jos.2018.03251. Epub 2019 Apr 17. No abstract available. PubMed 30991796 ↗
  • Smith CJ, Kishore AK, Vail A, Chamorro A, Garau J, Hopkins SJ, Di Napoli M, Kalra L, Langhorne P, Montaner J, Roffe C, Rudd AG, Tyrrell PJ, van de Beek D, Woodhead M, Meisel A. Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group. Stroke. 2015 Aug;46(8):2335-40. doi: 10.1161/STROKEAHA.115.009617. Epub 2015 Jun 25. PubMed 26111886 ↗
  • Eltringham SA, Kilner K, Gee M, Sage K, Bray BD, Smith CJ, Pownall S. Factors Associated with Risk of Stroke-Associated Pneumonia in Patients with Dysphagia: A Systematic Review. Dysphagia. 2020 Oct;35(5):735-744. doi: 10.1007/s00455-019-10061-6. Epub 2019 Sep 6. PubMed 31493069 ↗
  • Burgos R, Breton I, Cereda E, Desport JC, Dziewas R, Genton L, Gomes F, Jesus P, Leischker A, Muscaritoli M, Poulia KA, Preiser JC, Van der Marck M, Wirth R, Singer P, Bischoff SC. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018 Feb;37(1):354-396. doi: 10.1016/j.clnu.2017.09.003. Epub 2017 Sep 22. PubMed 29274834 ↗
  • Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, Drury P, Griffiths R, Cheung NW, Quinn C, Evans M, Cadilhac D, Levi C; QASC Trialists Group. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011 Nov 12;378(9804):1699-706. doi: 10.1016/S0140-6736(11)61485-2. Epub 2011 Oct 11. PubMed 21996470 ↗
  • Pudar J, Strong B, Howard VJ, Reeves MJ. Reporting of Results by Sex in Randomized Controlled Trials of Acute Stroke Therapies (2010-2020). Stroke. 2021 Nov;52(11):e702-e705. doi: 10.1161/STROKEAHA.120.034099. Epub 2021 Sep 16. PubMed 34525839 ↗
  • Strong B, Pudar J, Thrift AG, Howard VJ, Hussain M, Carcel C, de Los Campos G, Reeves MJ. Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis. JAMA Neurol. 2021 Jun 1;78(6):666-677. doi: 10.1001/jamaneurol.2021.0873. PubMed 33900363 ↗
  • Rexrode KM, Madsen TE, Yu AYX, Carcel C, Lichtman JH, Miller EC. The Impact of Sex and Gender on Stroke. Circ Res. 2022 Feb 18;130(4):512-528. doi: 10.1161/CIRCRESAHA.121.319915. Epub 2022 Feb 17. PubMed 35175851 ↗
  • Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, Kutluk K, Mikulik R, Wardlaw J, Richard E, Nabavi D, Molina C, Bath PM, Stibrant Sunnerhagen K, Rudd A, Drummond A, Planas A, Caso V. Action Plan for Stroke in Europe 2018-2030. Eur Stroke J. 2018 Dec;3(4):309-336. doi: 10.1177/2396987318808719. Epub 2018 Oct 29. PubMed 31236480 ↗
  • Alvarez-Sabin J, Quintana M, Masjuan J, Oliva-Moreno J, Mar J, Gonzalez-Rojas N, Becerra V, Torres C, Yebenes M; CONOCES Investigators Group. Economic impact of patients admitted to stroke units in Spain. Eur J Health Econ. 2017 May;18(4):449-458. doi: 10.1007/s10198-016-0799-9. Epub 2016 Apr 15. PubMed 27084749 ↗
  • Ruiz Alvarez M, Aginagalde Llorente AH, Del Llano Senaris JE. [Los determinantes sociales de la salud en Espana (2010-2021): una revision exploratoria de la literatura.]. Rev Esp Salud Publica. 2022 May 12;96:e202205041. Spanish. PubMed 35582978 ↗

Individual participant data

Plan to share: Undecided — The decision to share individual participant data has not yet been determined. The study involves sensitive, coded clinical data, with access restricted to the research team.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07627399
Collaborators
Instituto de Salud Carlos III, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, Andalusian Health Service
Responsible party
JOSE MIGUEL MORALES ASENCIO (Professor / Principal Investigator, University of Malaga) — Principal investigator
First posted
Jun 4, 2026
Start date
May 12, 2026
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jun 4, 2026

Study contacts

JOSE MIGUEL MORALES-ASENCIO, PhD
Contact
jmmasen@uma.es
+34951952833
Laura Gutierrez Rodriguez, PhD
Contact
laura_gr@uma.es
+34951952880
JOSE MIGUEL MORALES-ASENCIO, PhD
principal investigator · Universidad de Málaga

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion